Delivery Order SPE2DB20D3304-SPE2DB25FW5F2

Award Date 1/28/25
Potential Completion Date 1/29/25
Potential Value $5.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,927.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. This is a firm-fixed-price delivery order contract with a completion date of July 24, 2023. The contract is not associated with any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award, valued at $10,899.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $1,380.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract has an ultimate completion date of December 4, 2024 and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is the...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a firm fixed price of $1,741.68 and a completion date of July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $5,072.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used for the treatment of diabetes. The contract has a completion date of June 3, 2024 and is structured as a firm-fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $17,378.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication commonly used to treat diabetes. The contract has an ultimate completion date of November 18, 2024 and is priced on a Firm Fixed Price basis. The contract is not designated with a set-aside...
This federal contract award, valued at $11,809.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used for the treatment of diabetes. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 25, 2024. It is not designated as a set-aside contract,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies. The $6,993.36 firm fixed-price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,506.36 delivery order contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price arrangement. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,543.96, is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of December 3, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
  • SPE2DB20D3304
    Indefinite Delivery Contract
  • SPE2DB20D3304-SPE2DB25FW5F2
    Delivery Order

This federal contract award, valued at $5,405.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract has an ultimate completion date of January 29, 2025 and is a firm-fixed-price delivery order. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/29/25, 9:58 AM